Myogen Ambrisentan On-Track For Late 2006 Pulmonary Hypertension NDA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Myogen appears on-track to file ambrisentan for treatment of pulmonary arterial hypertension by year-end 2006